TH07 was designed for synergy, not just addition.
Androgenetic alopecia is a multi-pathway disease, so addressing one pathway is rarely enough. TH07 is built on one insight: combining ingredients that address complementary pathways may amplify their individual effects. Results from the published proof-of-concept study support this rationale (Sekhavat et al., 2024).
The
DHT
pathway
Dihydrotestosterone (DHT) miniaturizes hair follicles in genetically susceptible individuals.
The
growth-cycle
pathway
Follicles shift too early from growth (anagen) to rest (telogen), shortening the growth phase.
The follicle-
environment
pathway
Chronic micro-inflammation, reduced blood flow and perifollicular fibrosis impair follicle function.
Synergy and topical delivery
One spray. Three ingredients. Designed to work together.
TH07 pairs each pathway with an ingredient whose mechanism is described in the scientific literature, delivered through a proprietary topical vehicle designed to keep delivery local to the scalp.
- Finasteride: a 5-alpha-reductase inhibitor that lowers DHT, the key driver of follicle miniaturization1.
- Minoxidil: stimulates follicular activity and prolongs the growth phase; approved for androgenic alopecia2.
- Latanoprost: a prostaglandin F2α analogue that acts on prostaglandin receptors in the hair follicle and is being studied for its role in prolonging the hair growth (anagen) phase.
Minoxidil: the growth stimulator2.
Finasteride: the DHT blocker1.
Latanoprost: studied for thickness and pigmentation.
In TH07 they are combined in a single once-daily spray, designed so each can amplify the others.
1Kaufman et al., J Am Acad Dermatol 1998; finasteride product monograph
2Messenger and Rundegren, Br J Dermatol 2004
Designed for once-daily, scalp-targeted use
The best treatment is the one people actually stay on.
Many people stop topical hair-loss treatments because the routine is hard to keep up with. TH07 was designed with that in mind: once-daily dosing, a clean spray designed to leave no residue, and scalp-targeted delivery.
A better experience drives better compliance, and better compliance drives better results.
- Once-daily dosing by design.
- A non-greasy, non-sticky spray designed to leave no residue.
- Scalp-targeted delivery, designed to keep the ingredients local to the scalp.
RECENT PUBLICATIONS
Corporate and scientific news
Behind Triple Hair is a team of dedicated scientists, clinicians and innovators who refuse to settle for incremental progress. Together, they are building a development pipeline led by TH07, with the aim of redefining what is possible in hair loss care.
STAY UP TO DATE